Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laurence Crouzet
Observed name:
L. Crouzet
Institution:
Centre Eugène Marquis
Observed institutions:
Inserm,
Centre Eugène Marquis,
Hôpital Pontchaillou
OpenAlex ID:
A5082556133
Immunotherapy in Renal Cell Carcinoma: The Future Is Now
2020
·
Antoine Deleuze
, Judikaël Saout
, et al.
·
International Journal of Molecular Sciences
·
250
PDF
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis
2015
·
Julien Edeline
, Laurence Crouzet
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
93
Independent association of PD‐L1 expression with noninactivated VHL clear cell renal cell carcinoma—A finding with therapeutic potential
2016
·
Solène‐Florence Kammerer‐Jacquet
, Laurence Crouzet
, et al.
·
International Journal of Cancer
·
56
Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma
2021
·
Lucia Carril-Ajuria
, Emeline Colomba
, et al.
·
European Journal of Cancer
·
51
PDF
Development of multiplex digital PCR assays for the detection of PIK3CA mutations in the plasma of metastatic breast cancer patients
2021
·
Julien Corné
, Fanny Le Du
, et al.
·
Scientific Reports
·
38
PDF
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study
2022
·
Charles Vauchier
, Edouard Auclin
, et al.
·
Journal of Oncology
·
32
PDF
Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors
2014
·
Julien Edeline
, Laurence Crouzet
, et al.
·
Cancer Chemotherapy and Pharmacology
·
25
Implementation of a Nurse-driven Educational Program Improves Management of Sorafenib’s Toxicities in Hepatocellular Carcinoma
2017
·
Angélique Brunot
, Florence Le Roy
, et al.
·
Cancer Nursing
·
20
Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial)
2021
·
Volkmar Mueller
, Andrew Wardley
, et al.
·
European Journal of Cancer
·
19
PDF
Development of sensitive and robust multiplex digital PCR assays for the detection of ESR1 mutations in the plasma of metastatic breast cancer patients
2023
·
Julien Corné
, Véronique Quillien
, et al.
·
Clinica Chimica Acta
·
14
Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability
2015
·
Julien Edeline
, Cédric Coulouarn
, et al.
·
Journal of Vascular and Interventional Radiology
·
11
652P BT8009 monotherapy in enfortumab vedotin (EV)-naïve patients (pts) with metastatic urothelial carcinoma (mUC): Updated results of Duravelo-1
2024
·
O. Reig Torras
, L. Crouzet
, et al.
·
Annals of Oncology
·
8
PDF
Plasma‐based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer
2024
·
Julien Corné
, Véronique Quillien
, et al.
·
Molecular Oncology
·
8
PDF
Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma
2022
·
Lucie Meynard
, Derek Dinart
, et al.
·
European Journal of Cancer
·
7
PDF
Haemolytic uremic syndrome and gemcitabine: Jaundice is not always progression in cholangiocarcinoma
2012
·
Laurence Crouzet
, Julien Edeline
, et al.
·
Acta Oncologica
·
6
PDF
Impact of EPclin on adjuvant therapeutic decision making and comparison of EPclin to the PREDICT tool
2021
·
Héloïse Bourien
, Véronique Quillien
, et al.
·
The International Journal of Biological Markers
·
5
Therapeutic innovations in breast cancer
2019
·
Fanny Le Du
, Christophe Perrin
, et al.
·
La Presse Médicale
·
5
PDF
Abstract PD13-04: Impact of tucatinib on health-related quality of life in patients with HER2+ metastatic breast cancer with stable and active brain metastases
2021
·
Andrew Wardley
, Volkmar Mueller
, et al.
·
Cancer Research
·
4
Les infirmières cliniciennes améliorent la gestion des toxicités des patients traités par sorafénib pour carcinome hépatocellulaire
2016
·
Angélique Brunot
, Amel M'Sadek
, et al.
·
Bulletin du Cancer
·
4
Benefit of IMRT in High Dose Prostate Cancer Radiotherapy
2010
·
R. de Crevoisier
, C. Chira
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
3
Comparative Performance of a Targeted Next-Generation Sequencing Assay Against Multiplexed Digital PCR Assays in Detecting ERBB2, ESR1, and PIK3CA Mutations in Plasma Circulating Cell-Free DNA from Liquid Biopsies
2025
·
Julien Corné
, Florence Godey
, et al.
·
Journal of Molecular Diagnostics
·
2
Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients
2025
·
Ilfad Blazevic
, Aude Fléchon
, et al.
·
BJUI Compass
·
2
PDF
Rechallenge of nivolumab in metastatic renal cell carcinoma, an ambispective multicenter study (RENIVO).
2021
·
Charles Vauchier
, Edouard Auclin
, et al.
·
Journal of Clinical Oncology
·
2
Zelenectide pevedotin (BT8009) monotherapy in previously treated metastatic urothelial carcinoma (mUC): Update on Duravelo-1.
2026
·
Oscar Reig Torras
, Laurence Crouzet
, et al.
·
Journal of Clinical Oncology
·
1
Tivozanib for hepatocellular carcinoma: not likely a new option
2020
·
Florian Estrade
, Fanny Le Du
, et al.
·
Annals of Translational Medicine
·
1
PDF
Show more works
View as search
Works count:
43
Citation count:
671
H-index:
11
I10-index:
11
Year
Topic
Type